2 completed, 1 active not recruiting, 1 not yet recruiting. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Active not recruiting 1, Not yet recruiting 1 |
Follow Ali Aminian: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Metabolic Surgery for Atrial Fibrillation Elimination Roux-en-Y Gastric Bypass or Sleeve Gastrectomy, Anti-Obesity Medication (AOM) treatment - Atrial Fibrillation, Obesity and Obesity-related Medical Conditions | Phase 4 | Not yet recruiting | Ali Aminian | 100 | 2026-11-01 | 2026-04-17 |
| Bariatric Surgery vs. Semaglutide vs. Tirzepatide Bariatric Surgery, Semaglutide, Tirzepatide - Obesity and Obesity-related Medical Conditions | Phase 4 | Active not recruiting | Ali Aminian | 140 | 2025-01-29 | 2026-09-03 |
| Alliance of Randomized Trials of Medicine vs Metabolic Surgery in Type 2 Diabetes Bariatric surgery involving Roux-en-Y gastric bypass, Bariatric surgery involving Laparoscopic adjustable gastric banding, Bariatric surgery involving Laparoscopic sleeve gastrectomy - Type 2 Diabetes Mellitus, Obesity | Completed | Ali Aminian | 262 | 2018-04-10 | 2026-03-31 | |
| Macrovascular and Microvascular Morbidity and Mortality After Metabolic Surgery Versus Medicines Type 2 Diabetes Mellitus, Obesity | Completed | Ali Aminian | 3932 | 2010-01-01 | 2024-05-21 |
Obesity (4) · Diabetes Mellitus, Type 2 (2) · Atrial Fibrillation (1) · Heart Failure (1) · Kidney Diseases (1) · Metabolic Syndrome (1) · Retinal Diseases (1)
Bariatric Surgery (2) · Gastric Bypass (2) · Collagen Type II (1) · Therapeutics (1) · Tirzepatide (1) · semaglutide (1)
United States (3)
Ali Aminani (1) · Aminian Ali, MD (1) · John Kirwan, PhD (1)
PMID 35320365, PMID 38411644, PMID 41554124
U01DK114156 (1)